CFOPharmaMedTech
Available

Interim CFO

📍 Poznan⏱ 14–19 yrs★ 4.6 / 5

Financing R&D projects in biotech and medtech. Familiar with FDA/EMA regulations and innovation funding models.

R&D FinancePharmaRegulations

Selected missions

2022–2024
Biotech scale-up (anonymized)

Raised 35M EUR Series B, grant + equity structure.

2020–2021
MedTech (anonymized)

Prepared the company for due diligence by a global fund.

Competences

R&D financingGrant managementFDA/EMA complianceM&A pharmaTransfer pricingSR&ED tax credits